Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Bristol-Myers Squibb’s daclatasvir, asunaprevir and beclabuvir cured high rates of hepatitis C virus (HCV) among those with genotype 1...
Twelve weeks of Harvoni yielded a 98 percent hepatitis C cure rate among those with genotype 1 of the virus who are coinfected with HIV.
Viekira Pak plus ribavirin boasts a hep C cure rate in the low-90 percent range among those with genotype 1 who are coinfected with HIV.
People who have hepatitis C and advanced liver fibrosis or cirrhosis and are cured of the virus may experience normal lifespan.
Reaching an undetectable hepatitis C viral load is linked to diminished chances of liver disease and liver-related death.
Sofosbuvir and ribavirin demonstrated moderate success in curing a group of people with hepatitis C who had various attributes challenging..
The rates of liver cancer in the United States more than doubled between 1990 and 2010 while deaths resulting from cirrhosis jumped 43 percent...
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.